Nuwellis, Inc. Common Stock (NUWE)
Nuwellis, Inc. (NUWE) is a medical device company focused on developing and commercializing innovative solutions for fluid management, primarily in critical care and dialysis markets. The company specializes in hemodialysis and ultrafiltration therapies, offering products designed to improve patient outcomes and streamline treatment protocols.
Company News
Nuwellis has signed a non-binding letter of intent to acquire Rendiatech, an Israeli medical device company specializing in real-time urine flow and acute kidney injury monitoring technologies, potentially expanding its fluid management technology platform.
Nuwellis held a Special Meeting of Stockholders, where shareholders approved proposals to increase authorized shares, potentially conduct a reverse stock split, and issue shares from a recent financing to enhance financial flexibility.
Nuwellis Inc experienced a dramatic 200% stock surge in premarket trading after receiving a new U.S. patent for an improved extracorporeal blood filtering machine that enhances fluid balance calculation accuracy in continuous renal replacement therapy systems.
Can these tips help you to profit with energy penny stocks? The post Energy Penny Stocks, 3 Tips for Profiting in 2024 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Nuwellis, Inc. (NUWE) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.